100
Participants
Start Date
July 7, 2025
Primary Completion Date
November 30, 2026
Study Completion Date
November 30, 2027
Intervention: MRI-Linac SABR
The treatment planning protocol follows the UK SABR Consortium Guidelines. Patients will be prescribed the maximum isotoxic dose achievable while meeting normal organ tolerances (normal liver, kidney, spinal cord, stomach, duodenum, small and large bowel, heart, lungs, chest wall). The lowest acceptable SABR doses are indicated in the dose range Table within the protocol. The maximum dose/fraction also indicates the maximum the dose can be escalated to for each adaptive session on the MRI-Linac.
RECRUITING
GenesisCare - St Vincent's Sydney, Darlinghurst
NOT_YET_RECRUITING
Austin Health, Melbourne
Trans Tasman Radiation Oncology Group
OTHER
Australasian Gastro-Intestinal Trials Group
NETWORK